The sequences between 0.59 and 0.54 map units on SV40 DNA code for the unique region of small t antigen.

PubWeight™: 1.34‹?› | Rank: Top 10%

🔗 View Article (PMID 215314)

Published in Cell on November 01, 1978

Authors

E Paucha, A E Smith

Articles citing this

Nucleotide sequence deletions within the coding region for small-t antigen of simian virus 40. J Virol (1979) 2.23

Simian virus 40 mutants with deletions at the 3' end of the early region are defective in adenovirus helper function. J Virol (1979) 2.01

Translation and developmental regulation of RNA encoded by the eukaryotic transposable element copia. Proc Natl Acad Sci U S A (1980) 1.80

Nucleotide sequence analysis of two simian virus 40 mutants with deletions in the region coding for the carboxyl terminus of the T antigen. J Virol (1979) 1.78

Differentiation as a requirement for simian virus 40 gene expression in F-9 embryonal carcinoma cells. Proc Natl Acad Sci U S A (1979) 1.67

Simian virus 40 gene A regulation of cellular DNA synthesis. II. In nonpermissive cells. J Virol (1981) 1.51

DNA binding properties of simian virus 40 T-antigens synthesized in vivo and in vitro. J Virol (1980) 1.24

Construction and characterization of viable deletion mutants of simian virus 40 lacking sequences near the 3' end of the early region. J Virol (1982) 1.23

Structure and synthesis of a simian virus 40 super T-antigen. J Virol (1982) 1.21

Characterization of the 5'-terminal structure of simian virus 40 early mRNA's. J Virol (1979) 1.10

Structure and biochemical functions of four simian virus 40 truncated large-T antigens. J Virol (1982) 1.07

Simian virus 40 T-antigen: identification of tryptic peptides in the C-terminal region and definition of the reading frame. J Virol (1980) 1.05

Unusual regulation of simian virus 40 early-region transcription in genomes containing two origins of DNA replication. Mol Cell Biol (1984) 1.05

An antibody to a synthetic peptide that recognises SV40 small-t antigen. EMBO J (1982) 1.03

Partial amino-terminal sequences of the polyoma nonhistone proteins VP1, VP2, and VP3 synthesized in vitro. J Virol (1980) 0.86

Immunoprecipitation of some forms of simian virus 40 large-T antigen by antibodies to synthetic peptides. J Virol (1984) 0.86

Articles by these authors

A short amino acid sequence able to specify nuclear location. Cell (1984) 21.17

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69

The isolation and properties of the monoglucuronides of stilboestrol, hexoestrol and dienoestrol. Biochem J (1948) 10.61

Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature (1984) 10.52

Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell (1990) 9.21

Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature (1992) 8.47

Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature (1983) 7.20

Organization and expression of early genes of simian virus 40. Proc Natl Acad Sci U S A (1978) 7.10

Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell (1993) 6.25

Translation of RNA from encephalomyocarditis virus in a mammalian cell-free system. Nature (1970) 5.89

Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell (1987) 5.84

Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science (1991) 5.82

Nuclear location signals in polyoma virus large-T. Cell (1986) 5.74

Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature (1990) 4.26

SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell (1989) 3.88

Protein kinase activity associated with polyoma virus middle T antigen in vitro. Cell (1979) 3.78

Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell (1991) 3.75

The complex of polyoma virus middle-T antigen and pp60c-src. EMBO J (1984) 3.57

In vitro mutagenesis of a putative DNA binding domain of SV40 large-T. Virology (1984) 3.50

Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell (1993) 3.47

Generation of cAMP-activated chloride currents by expression of CFTR. Science (1991) 3.45

Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties. Nature (1993) 3.43

Characterization of different tumor antigens present in cells transformed by simian virus 40. Cell (1979) 3.26

Nucleoside triphosphates are required to open the CFTR chloride channel. Cell (1991) 3.21

Cytoplasmic methionine transfer RNAs from eukaryotes. Nature (1970) 3.12

Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature (1990) 3.09

Large and small tumor antigens from simian virus 40 have identical amino termini mapping at 0.65 map units. Proc Natl Acad Sci U S A (1978) 3.00

The effect of protein context on nuclear location signal function. Cell (1987) 2.83

An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell (1989) 2.78

Cell-free translation of virion RNA from nondefective and transformation-defective Rous sarcoma viruses. J Virol (1976) 2.68

Gene probe analysis of soil microbial populations selected by amendment with 2,4-dichlorophenoxyacetic acid. Appl Environ Microbiol (1992) 2.66

Monomer molecular weight of T antigen from simian virus 40-infected and transformed cells. Proc Natl Acad Sci U S A (1976) 2.64

Extraction and fingerprint analysis of simian virus 40 large and small T-antigens. J Virol (1978) 2.50

Cell-free synthesis of simian virus 40 T-antigens. J Virol (1978) 2.32

Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol (1991) 2.25

Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus. EMBO J (1988) 2.25

Concomitance of psoriasis and atopic dermatitis. Dermatology (1992) 2.18

The nuclear location signal. Proc R Soc Lond B Biol Sci (1985) 2.14

Sodium ions and the shut-off of host cell protein synthesis by picornaviruses. Nature (1977) 2.12

PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gene Ther (1999) 2.11

Effect of deleting the R domain on CFTR-generated chloride channels. Science (1991) 2.09

Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia. J Clin Invest (1992) 1.93

N-formylmethionyl transfer RNA in mitochondria from yeast and rat liver. J Mol Biol (1968) 1.93

The size of Rous sarcoma virus mRNAs active in cell-free translation. Nature (1977) 1.92

The initiation of protein synthesis directed by the RNA from encephalomyocarditis virus. Eur J Biochem (1973) 1.91

Deletion loop mutagenesis: a novel method for the construction of point mutations using deletion mutants. Nucleic Acids Res (1982) 1.90

Initiator codons in eukaryotes. Nature (1970) 1.89

Simian virus 40 origin DNA-binding domain on large T antigen. J Virol (1986) 1.80

Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by negative charge in the R domain. J Biol Chem (1993) 1.80

Dissociation of Rb-binding and anchorage-independent growth from immortalization and tumorigenicity using SV40 mutants producing N-terminally truncated large T antigens. Virology (1990) 1.77

Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosis. Hum Gene Ther (1993) 1.72

Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. J Clin Invest (1991) 1.71

Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69

Extensive mutagenesis of the nuclear location signal of simian virus 40 large-T antigen. Mol Cell Biol (1986) 1.65

Location of the sequences coding for capsid proteins VP1 and VP2 on polyoma virus DNA. Cell (1976) 1.63

Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A, and myc oncoproteins. J Virol (1988) 1.63

Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet (1994) 1.62

Specificity in initiation of protein synthesis in a fractionated mammalian cell-free system. Nat New Biol (1973) 1.56

An integrated assessment framework for climate change and infectious diseases. Environ Health Perspect (1999) 1.54

Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis. Nature (1983) 1.52

Identification of a region of simian virus 40 large T antigen required for cell transformation. J Virol (1990) 1.50

Coordination of velopharyngeal muscle activity during positioning of the soft palate. Cleft Palate Craniofac J (1994) 1.49

Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulation. Neuron (1992) 1.46

Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J Virol (1997) 1.46

Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum Gene Ther (1995) 1.43

Primary and secondary prevention services in clinical practice. Twenty years' experience in development, implementation, and evaluation. JAMA (1995) 1.36

Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro. J Biol Chem (1994) 1.35

Initiation of translation directed by 42S and 26S RNAs from Semliki Forest virus in vitro. Proc Natl Acad Sci U S A (1976) 1.35

Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro. Hum Gene Ther (1994) 1.33

The T/t common region of simian virus 40 large T antigen contains a distinct transformation-governing sequence. J Virol (1991) 1.32

Polyoma virus has three late mRNA's: one for each virion protein. J Virol (1978) 1.31

In vitro synthesis, glycosylation, and membrane insertion of influenza virus haemagglutinin. Virology (1979) 1.31

Increasing speech intelligibility in children with autism. J Autism Dev Disord (1998) 1.31

Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum Gene Ther (1997) 1.30

Biophysical characterization of cationic lipid: DNA complexes. Biochim Biophys Acta (1997) 1.30

Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation. EMBO J (1986) 1.27

Use of probabilistic expert judgment in uncertainty analysis of carcinogenic potency. Regul Toxicol Pharmacol (1994) 1.27

Signal-dependent translocation of simian virus 40 large-T antigen into rat liver nuclei in a cell-free system. Mol Cell Biol (1987) 1.26

The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus. Mol Cell Biol (1988) 1.26

Separation of simian virus 40 large-T-antigen-transforming and origin-binding functions from the ability to block differentiation. Mol Cell Biol (1988) 1.25

In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen. J Virol (1986) 1.24

Biochemical characterization of phosphorylation site mutants of simian virus 40 large T antigen: evidence for interaction between amino- and carboxy-terminal domains. J Virol (1991) 1.23

Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther (1996) 1.23

Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein. Proc Natl Acad Sci U S A (1994) 1.22

Mutants of polyomavirus middle-T antigen. Biochim Biophys Acta (1987) 1.22

Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J Virol (1996) 1.22

Structure and synthesis of a simian virus 40 super T-antigen. J Virol (1982) 1.21

Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method. Gene Ther (1996) 1.20

T antigens of SV40-transformed cells. Cold Spring Harb Symp Quant Biol (1980) 1.20

Cystic fibrosis. Sci Am (1995) 1.20

Synthesis of viral-specific polypeptides in Mengo virus-infected L cells: evidence for asymmetric translation of the viral genome. Virology (1974) 1.19

Cell-free synthesis of polyoma virus capsid proteins VP1 and VP2. J Virol (1977) 1.18